K954301 is an FDA 510(k) clearance for the ABBOTT CMV TOTAL ANTIBODY EIA (MODIFICATION). This device is classified as a Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus (Class II - Special Controls, product code LFZ).
Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on March 24, 1997, 579 days after receiving the submission on August 23, 1995.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3175.
| 510(k) Number | K954301 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | August 23, 1995 |
| Decision Date | March 24, 1997 |
| Days to Decision | 579 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LFZ — Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.3175 |